CD07805/47 gel 0.5%
Sponsors
Galderma R&D
Conditions
ErythemaRosacea
Phase 3
Study of CD07805/47 Topical Gel in Subjects With Facial Erythema Associated With Rosacea
CompletedNCT01318733
Start: 2011-03-31End: 2012-07-31Updated: 2021-02-18
Phase 3 Efficacy and Safety Study of CD07805/47 Topical Gel in Subjects With Persistent Facial Erythema
WithdrawnNCT01882712
Updated: 2014-11-06